Hilary Beggs

Hilary Beggs is an accomplished Executive Director and Program Team Leader at Ultragenyx Pharmaceutical Inc., overseeing the development of therapies for rare diseases from early preclinical stages to commercialization across various global markets. Prior experience includes leadership roles at Calico Life Sciences LLC, where Hilary guided cross-functional teams in aging-related therapeutic development, and as a Director at Pfizer Worldwide R&D, focusing on cancer immunotherapy and other therapeutic areas. An academic background includes a tenure as an Assistant Professor at UCSF, emphasizing neuroscience and ophthalmology, complemented by extensive experience in research and development across biotech and pharmaceutical sectors. Hilary holds a PhD in Neurobiology and Neurosciences from the University of North Carolina at Chapel Hill, along with a Post Doctoral Fellowship in Cellular Signaling Pathways from UCSF and a Bachelor of Science in Biology from Washington and Lee University.